Kalehua Capital Management LLC 13F holdings
Kalehua Capital Management LLC reported 26 positions with a total reported value of $313.5M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-19. Top holdings by reported value: MANE Veradermics Inc (11.4%), XFOR X4 Pharmaceuticals Inc (11.1%), EA SERIES TRUST (8.4%), CMPS Compass Pathways Plc (7.4%), SRZN Surrozen Inc (6.4%). Against 2026-03-31 it opened 9 new positions and exited 8. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Kalehua Capital Management LLC files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
25 largest of 26 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| MANE Veradermics Inc | 291,390 | $35.8M | 11.4% |
| XFOR X4 Pharmaceuticals Inc | 7,445,680 | $34.8M | 11.1% |
| EA SERIES TRUST | 226,188 | $26.5M | 8.4% |
| CMPS Compass Pathways Plc | 1,639,384 | $23.2M | 7.4% |
| SRZN Surrozen Inc | 770,356 | $20.0M | 6.4% |
| ACRS Aclaris Therapeutics Inc | 3,664,730 | $19.4M | 6.2% |
| SION Sionna Therapeutics Inc | 394,144 | $17.3M | 5.5% |
| IKT Inhibikase Therapeutics Inc | 7,643,780 | $15.5M | 4.9% |
| PHVS Pharvaris NV | 397,544 | $13.7M | 4.4% |
| KPTI Karyopharm Therapeutics Inc | 1,371,288 | $13.4M | 4.3% |
| SEPN Septerna Inc | 389,088 | $13.0M | 4.2% |
| IFRX Inflarx Nv | 5,795,538 | $13.0M | 4.1% |
| Cyclerion Therapeutics Inc | 3,302,700 | $11.2M | 3.6% |
| QURE Uniqure Nv | 158,814 | $7.3M | 2.3% |
| LONA LeonaBio Inc | 787,402 | $7.2M | 2.3% |
| DMRA Damora Therapeutics Inc | 278,000 | $7.2M | 2.3% |
| MLTX MoonLake Immunotherapeutics | 351,468 | $6.8M | 2.2% |
| KRRO Korro Bio Inc | 405,040 | $5.3M | 1.7% |
| TYRA Tyra Biosciences Inc | 148,930 | $4.8M | 1.5% |
| NVCT Nuvectis Pharma Inc | 200,000 | $3.7M | 1.2% |
| GOSS Gossamer Bio Inc | 22,298,726 | $3.7M | 1.2% |
| MIST Milestone Pharmaceuticals Inc | 2,538,474 | $3.4M | 1.1% |
| ANL Adlai Nortye | 226,415 | $2.6M | 0.8% |
| ATYR Atyr Pharma Inc | 3,576,334 | $2.1M | 0.7% |
| TIL Instil Bio Inc | 199,200 | $1.5M | 0.5% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 9 in all · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| EA SERIES TRUST | 226,188 | $26.5M | 8.4% |
| KPTI Karyopharm Therapeutics Inc | 1,371,288 | $13.4M | 4.3% |
| IFRX Inflarx Nv | 5,795,538 | $13.0M | 4.1% |
| Cyclerion Therapeutics Inc | 3,302,700 | $11.2M | 3.6% |
| NVCT Nuvectis Pharma Inc | 200,000 | $3.7M | 1.2% |
| MIST Milestone Pharmaceuticals Inc | 2,538,474 | $3.4M | 1.1% |
| ANL Adlai Nortye | 226,415 | $2.6M | 0.8% |
| ATYR Atyr Pharma Inc | 3,576,334 | $2.1M | 0.7% |
| TCRX Tscan Therapeutics Inc | 909,752 | $891.6K | 0.3% |
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 8 in all · reported value as of 2026-03-31
| Holding | Shares 2026-03-31 | Reported value | % of portfolio then |
|---|---|---|---|
| Alpha Architect 1-3 Month Box ETF | 336,700 | $39.2M | 15.1% |
| RLAY Relay Therapeutics Inc | 1,802,914 | $17.9M | 6.9% |
| ORKA Oruka Therapeutics Inc | 237,048 | $11.6M | 4.5% |
| PEPG PepGen Inc | 1,729,961 | $3.1M | 1.2% |
| TNYA Tenaya Therapeutics Inc | 4,000,000 | $2.8M | 1.1% |
| KLRS Kalaris Therapeutics Inc | 271,170 | $1.6M | 0.6% |
| DMAC DiaMedica Therapeutics Inc | 124,976 | $846.1K | 0.3% |
| LONGEVERON INC | 347,539 | $361.4K | 0.1% |
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| MANE Veradermics Inc | 248,574 | 291,390 | +17.2% | $35.8M |
| KRRO Korro Bio Inc | 109,376 | 405,040 | +270.3% | $5.3M |
| ACRS Aclaris Therapeutics Inc | 3,169,921 | 3,664,730 | +15.6% | $19.4M |
| IKT Inhibikase Therapeutics Inc | 6,494,498 | 7,643,780 | +17.7% | $15.5M |
| GOSS Gossamer Bio Inc | 17,708,133 | 22,298,726 | +25.9% | $3.7M |
Decreases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| QURE Uniqure Nv | 502,811 | 158,814 | -68.4% | $7.3M |
| TIL Instil Bio Inc | 322,879 | 199,200 | -38.3% | $1.5M |
CIK 2106181 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
